Addiction remains shrouded in stigma, while the system through which we provide addiction treatment in Australia is fragmented and failing. There’s no better time to address these issues.
Academic rigour, journalistic flair
Articles on Addiction
Displaying 61 - 80 of 292 articles
With the pressures of the holidays, rising COVID-19 rates and social isolation, people can easily fall into addictive-like behaviours. Here are some ways to challenge ourselves and family.
People with alcohol or substance dependency already struggle to access mental health treatment, covid will only make this worse.
It’s hard to get an accurate picture of how the pandemic has influenced drug use, but initial data suggests treatment services are reporting increased demand.
COVID-19 plagues an overtaxed opioid addiction treatment system.
If online shopping or browsing is interfering with your life, there a number of strategies you can try.
The brain’s immune system cells (called microglia) have already been shown to be involved in addiction to other substances.
From 2021, it will be harder to import e-cigarettes. That protects young people, in particular, who are increasingly being lured into nicotine and tobacco addiction.
Continued drug dependence treatment for people locked down in housing estates is important. But people not currently in treatment also need support.
From 2021, Australians will no longer be able to buy nicotine-containing e-fluids, without both a prescription and someone licensed to import it for them, raising fears many will go back to smoking.
For many reasons, drug users are shifting from the use of conventional psychoactive drugs such as cannabis, cocaine and heroin to pharmaceutical drugs for non-medical purposes.
Excessive screen use has been linked to addictive behaviours, changes in mood, increased stress and difficulty sleeping - here’s how to take a break.
Are you drinking more while in lockdown? Here are some things to look out for if you’re concerned about how much alcohol you’re consuming at the moment.
Sales of alcohol have reported jumped by around a quarter as people bulk buy wine, beers and spirits. That could lead to a range of short-term and long-term problems.
Taking tranquilizers with opioids increases the risk of overdose tenfold.
Prices are surging amid shortages and panic-buying – and we could soon be facing a public health disaster.
Aggressive marketing of prescription opioids by pharmaceutical companies provided doctors with scant information about potential harmful effects.
A prominent paper on vaping and heart disease has been retracted.
Addiction to cocaine is wildly difficult to conquer. But physicians may soon have a new type of gene therapy for patients that makes the drug less alluring.
There’s widespread attention on the dangers of opioid addiction, but use of damaging crystal meth continues in the U.S., with police seizures rising.
Job Board
-
Clinical Education Coordinator - Speech Pathology
-
Centre of Excellence Chief Operating Officer, Quantum Biotechnology (QUBIC)
-
Director, Monash University Museum of Art (MUMA)
-
Data and Multimedia journalist
-
Executive Dean, Faculty of Business, Government and Law University of Canberra
Top contributors
-
Honorary Fellow, Department of Health Sciences, University of York
-
Director of the International Gaming Research Unit and Professor of Behavioural Addiction, Nottingham Trent University
-
Professor at the National Drug Research Institute (Melbourne), Curtin University
-
Professor in Substance Use, Liverpool John Moores University
-
Reader in Crimimology and Social Policy, University of Birmingham
-
Executive Clinical Director, Turning Point & Director of Monash Addiction Research Centre, Monash University
-
Researcher: Digital Literacy and Digital Wellbeing, Western Sydney University
-
Associate Professor of Sociology, Bentley University
-
Associate Professor, School of Public Health, University of Sydney
-
Senior Research Fellow, Uehiro Centre for Practical Ethics, University of Oxford
-
Emeritus Professor, The National Centre for Youth Substance Use Research, The University of Queensland
-
Professor and Director of International Primary Health Care research Institute, Shenzhen, Australian National University
-
Professor, Federation University Australia
-
Senior Research Fellow, Monash University
-
PhD Candidate and Sessional Academic in History and Philosophy of Science, University of Sydney
